GlassScriptPhysician profile
Roman Shulkin
NPI 1710307731
$15,393.80
in general payments reported to CMS, 2019-2025
47 companies · $2,928 in 2025
The $2,928 reported for 2025 was more than what 85% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,631 · 2020: $360 · 2021: $2,427 · 2022: $1,402 · 2023: $1,926 · 2024: $2,720 · 2025: $2,928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,568 · Travel and Lodging: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,567.69 |
| Travel and Lodging | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,716.80 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Medtronic USA, INC. | $1,504.08 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $1,476.53 | 2020-2021 | |
| Abbott Laboratories | $1,235.88 | 2019-2024 | Eon C, Proclaim |
| Scilex Pharmaceuticals INC. | $1,199.37 | 2020-2025 | Ztlido |
| Abbvie INC. | $806.88 | 2021-2025 | Ubrelvy, Qulipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $746.12 | 2019-2025 | Relistor |
| Boston Scientific Corporation | $601.54 | 2019-2025 | General - Therapies, Intracept |
| Becton, Dickinson and Company | $550.00 | 2019 | |
| Nevro Corp. | $495.24 | 2022-2024 | Senza |
| Saluda Medical Americas, INC. | $356.40 | 2024-2025 | Evoke |
| Valinor Pharma, LLC | $300.34 | 2024-2025 | Movantik |
| Pfizer INC. | $257.50 | 2019-2024 | |
| Mml US, INC. | $255.34 | 2023 | Reactiv8 |
| Eisai INC. | $253.45 | 2024-2025 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roman Shulkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.